Epicardial fat: A new cardiovascular therapeutic target

Current Opinion in Pharmacology

Volumn 27, Issue , 2016, Pages 13-18

  Iacobellis, Gianluca ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LONG ACTING INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RECOMBINANT GROWTH HORMONE; CARDIOVASCULAR AGENT; FAT;

ARTICLE; CARDIOVASCULAR RISK; DRUG TARGETING; ECHOCARDIOGRAPHY; EPICARDIAL FAT; GENOMICS; HORMONE SUBSTITUTION; HUMAN; INTRAABDOMINAL FAT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; WEIGHT REDUCTION; ADIPOSE TISSUE; ANIMAL; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DRUG EFFECTS; METABOLISM; PERICARDIUM; RISK FACTOR;

ADIPOSE TISSUE; ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; FATS; HUMANS; PERICARDIUM; RISK FACTORS;

EID: 84970917683     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2016.01.004     Document Type: Review

References (41)

1. G. Iacobellis, D. Corradi, and A.M. Sharma Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart Nat Clin Pract Cardiovasc Med 2 2005 536 543
2. G. Iacobellis, and A.C. Bianco Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features Trends Endocrinol Metab 22 2011 450 457
3. T. Mazurek, L. Zhang, A. Zalewski, J.D. Mannion, J.T. Diehl, and H. Arafat Human epicardial adipose tissue is a source of inflammatory mediators Circulation 108 2003 2460 2466
4. G. Iacobellis Local and systemic effects of the multifaceted epicardial adipose tissue depot Nat Rev Endocrinol 11 2015 363 371
5. E.A. McAninch, T.L. Fonseca, R. Poggioli, A.L. Panos, T.A. Salerno, Y. Deng, Y. Li, A.C. Bianco, and G. Iacobellis Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease Obesity (Silver Spring) 23 2015 1267 1278
6. G. Iacobellis, and H.J. Willens Echocardiographic epicardial fat: a review of research and clinical applications J Am Soc Echocardiogr 22 2009 1311 1319
7. G. Iacobellis, F. Assael, M.C. Ribaudo, A. Zappaterreno, G. Alessi, U. Di Mario, and F. Leonetti Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction Obes Res 11 2003 304 310
8. S. Sarin, C. Wenger, A. Marwaha, A. Qureshi, B.D. Go, C.A. Woomert, K. Clark, L.A. Nassef, and J. Shirani Clinical significance of epicardial fat measured using cardiac multislice computed tomography Am J Cardiol 102 2008 767 771
9. G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, and F. Leonetti Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk J Clin Endocrinol Metab 388 2003 5163 5168
10. A.E. Malavazos, G. Di Leo, F. Secchi, E.N. Lupo, G. Dogliotti, C. Coman, L. Morricone, M.M. Corsi, F. Sardanelli, and G. Iacobellis Relation of echocardiographic epicardial fat thickness and myocardial fat Am J Cardiol 105 2010 1831 1835
11. M. Kankaanpää, H.R. Lehto, J.P. Pärkkä, M. Komu, A. Viljanen, E. Ferrannini, J. Knuuti, P. Nuutila, R. Parkkola, and P. Iozzo Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels J Clin Endocrinol Metab 91 2006 4689 4695
12. S.D. Pierdomenico, A.M. Pierdomenico, F. Cuccurullo, and G. Iacobellis Metaanalysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome Am J Cardiol 15 2012 1234 1236
13. G. Iacobellis, G. Barbarini, C. Letizia, and G. Barbaro Epícardial fat thickness and nonalcoholic fatty liver disease in obese subjects Obesity 22 2014 332 336
14. G. Iacobellis, and F. Leonetti Epicardial adipose tissue and insulin resistance in obese subjects J Clin Endocrinol Metab 90 2005 6300 6302
15. A.A. Mahabadi, N. Lehmann, H. Kälsch, T. Robens, M. Bauer, I. Dykun, T. Budde, S. Moebus, K.H. Jöckel, R. Erbel, and S. Möhlenkamp Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf Recall Study JACC Cardiovasc Imaging 7 2014 909 916
16. A.A. Mahabadi, M.H. Berg, N. Lehmann, H. Kälsch, M. Bauer, K. Kara, N. Dragano, S. Moebus, K.H. Jöckel, R. Erbel, and S. Möhlenkamp Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study J Am Coll Cardiol 61 2013 1388 1395
17. L.E. Sade, S. Eroglu, H. Bozbaş, S. Ozbiçer, M. Hayran, A. Haberal, and H. Müderrisoʇlu Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries Atherosclerosis 204 2009 580 585
18. G. Iacobellis, E. Lonn, A. Lamy, N. Singh, and A.M. Sharma Epicardial fat thickness and CAD correlate independently of obesity Int J Cardiol 146 2011 452 454
19. H.S. Sacks, J.N. Fain, P. Cheema, S.W. Bahouth, E. Garrett, and R.Y. Wolf Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone Diabetes Care 34 2011 730 733
20. E. Distel, G. Penot, T. Cadoudal, I. Balguy, S. Durant, and C. Benelli Early induction of a brown-like phenotype by rosiglitazone in the epicardial adipose tissue of fatty Zucker rats Biochimie 94 2012 1660 1667
21. S. Morano, E. Romagnoli, T. Filardi, L. Nieddu, E. Mandosi, M. Fallarino, I. Turinese, M.P. Dagostino, A. Lenzi, and V. Carnevale Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study Acta Diabetol 52 2015 727 732
22. J. Vendrell, R. El Bekay, B. Peral, E. García-Fuentes, A. Megia, M. Macias-Gonzalez, J. Fernández Real, Y. Jimenez-Gomez, X. Escoté, G. Pachón, and et al. Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance Endocrinology 152 2011 4072 4079
23. D. Beiroa, M. Imbernon, R. Gallego, A. Senra, D. Herranz, F. Villarroya, M. Serrano, J. Fernø, J. Salvador, J. Escalada, and et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK Diabetes 63 2014 3346 3358
24. J. Yang, J. Ren, J. Song, F. Liu, C. Wu, X. Wang, L. Gong, W. Li, F. Xiao, F. Yan, and et al. Glucagon-like peptide 1 regulates adipogenesis in 3 T3-L1 preadipocytes Int J Mol Med 31 2013 1429 1435
25. M.M. Lima-Martínez, M. Paoli, M. Rodney, N. Balladares, M. Contreras, L. D'Marco, and Iacobellis G Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study Endocrine 2015, August (Epub ahead of print)
26. M. Itou, T. Kawaguchi, E. Taniguchi, T. Oriishi, and M. Sata Dipeptidyl peptidase IV inhibitor improves insulin resistance and steatosis in a refractory nonalcoholic fatty liver disease patient: a case report Case Rep Gastroenterol 6 2012 538 544
27. G. Iacobellis, G. Barbarini, C. Letizia, and G. Barbaro Epícardial fat thickness and nonalcoholic fatty liver disease in obese subjects Obesity (Silver Spring) 22 2014 332 336
28. A. Aroor, S. McKarns, R. Nistala, V. DeMarco, M. Gardner, M. Garcia-Touza, and et al. DPP-4 inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renal insulin resistance in obesity and diabetes Cardiorenal Med 3 2013 48 56
29. Z. Shah, T. Kampfrath, J.A. Deiuliis, J. Zhong, C. Pineda, Z. Ying, and et al. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis Circulation 124 2011 2338 2349
30. T. Shimasaki, T. Masaki, K. Mitsutomi, D. Ueno, K. Gotoh, S. Chiba, T. Kakuma, and H. Yoshimatsu The dipeptidyl peptidase-4 inhibitor des-fluoro-sitagliptin regulates brown adipose tissue uncoupling protein levels in mice with diet-induced obesity PLOS ONE 8 2013 e63626
31. B. Elisha, M. Azar, N. Taleb, S. Bernard, G. Iacobellis, and R. Rabasa-Lhoret Body composition and epicardial fat in type 2 diabetes patients following insulin detemir versus insulin glargine initiation Horm Metab Res 2015, September [Epub ahead of print]
32. J.H. Park, Y.S. Park, Y.J. Kim, I.S. Lee, J.H. Kim, J.H. Lee, and et al. Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe J Cardiovasc Ultrasound 18 2010 121 126
33. N. Alexopoulos, B.H. Melek, C.D. Arepalli, G.R. Hartlage, Z. Chen, S. Kim, A.E. Stillman, and P. Raggi Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning) J Am Coll Cardiol 61 2013 1956 1961
34. L. Nasarre, O. Juan-Babot, P. Gastelurrutia, A. Llucia-Valldeperas, L. Badimon, A. Bayes-Genis, and V. Llorente-Cortés Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels Acta Diabetol 51 2014 23 30
35. A.F. Grosso, S.F. de Oliveira, L. Higuchi Mde, D. Favarato, L.A. Dallan, and P.L. da Luz Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome Diabetol Metab Syndr 6 2014 47
36. R. Lanes, A. Soros, K. Flores, P. Gunczler, E. Carrillo, and J. Bandel Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters J Clin Endocrinol Metab 90 2005 3978 3982
37. E. Ferrante, A.E. Malavazos, C. Giavoli, F. Ermetici, C. Coman, S. Bergamaschi, E. Profka, S. Briganti, C.L. Ronchi, E. Passeri, and et al. Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency Nutr Metab Cardiovasc Dis 23 2013 459 465
38. G. Iacobellis, N. Singh, S. Wharton, and A.M. Sharma Substantial changes in epicardial fat thickness after weight loss in severely obese subjects Obesity 16 2008 1693 1697
39. H.J. Willens, P. Byers, J.A. Chirinos, E. Labrador, J.M. Hare, and E. de Marchena Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography Am J Cardiol 99 2007 1242 1245
40. S.W. Rabkin, and H. Campbell Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis Obes Rev 16 2015 406 415
41. T. Mazurek, and G. Opolski Pericoronary adipose tissue: a novel therapeutic target in obesity-related coronary atherosclerosis J Am Coll Nutr 34 2015 244 254